Ovarian hyperstimulation syndrome-model rats; the manifestation and clinical implication

Molecular and Cellular Endocrinology

Volumn 202, Issue 1-2, 2003, Pages 47-52

  Ohba, Takashi ^a   Ujioka, Takeshi ^a   Ishikawa, Katsuyasu ^a   Tanaka, Nobuyuki ^a   Okamura, Hitoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Kinin kallikrein; Ovarian hyperstimulation; Progesterone; RU486; Vascular endothelial growth factor

Indexed keywords

ANTIGESTAGEN; CHORIONIC GONADOTROPIN; KININ; MIFEPRISTONE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL PERMEABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; IMMATURITY; LIVER; LUNG; NONHUMAN; ORGAN DISTRIBUTION; ORGAN WEIGHT; OVARY; OVARY HYPERSTIMULATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; SYNDROME; TRANSCRIPTION REGULATION;

EID: 0037613397     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(03)00061-3     Document Type: Conference Paper

References (32)

1. Abramov Y., Barak V., Nisman B., Schenker J.G. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil. Steril. 67:1997;261-265.
2. Agrawal R., Tan S.L., Wild S., Sladkevicius P., Engmann L., Payne N., et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil. Steril. 71:1999;287-293.
3. Anasti J.N., Kalantaridou S.N., Kimzey L.M., George M., Nelson L.M. Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles. Hum. Reprod. 1:(3):1998;1144-1147.
4. Artini P.G., Fasciani A., Monti M., Luisi S., D'Ambrogio G., Genazzani A.R. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil. Steril. 70:1998;560-564.
5. Brinsden P.R., Wada I., Tan S.L., Balen A., Jacobs H.S. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br. J. Obstet. Gynaecol. 102:1995;767-772.
6. Brown L.F., Berse B., Togazzi K., Manseau E.J., Van de Water L., Senger D.R., et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 42:1992;1457-1461.
7. Chen C.D., Wu M.Y., Chen H.F., Chen S.U., Ho H.N., Yang Y.S. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil. Steril. 72:1999;286-292.
8. Conn G., Bayne M.L., Soderman D.D., Kwok P.W., Sullvan K.A., Palisi T.M., et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelets-derived growth factor. Biochemistry. 87:1990;2628-2632.
9. Daniel Y., Geva E., Amit A., Baram A., Englander T., Kupferminc M.J., et al. Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 are increased in women with ovarian hyperstimulation syndrome. Fertil. Steril. 71:1999;896-901.
10. Dourron N.E., Williams D.B. Prevention and treatment of ovarian hyperstimulation syndrome. Semin. Reprod. Biol. 14:1996;355-365.
11. Ferrara N., Davis-Smith T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:1997;4-25.
12. Gaytan F., Morales C., Bellido C., Aguilar R., Millan Y., Martin De Las Mulas J., Sanchez-Criado J.E. Progesterone on an oestrogen background enhances prolactin-induced apoptosis in regressing corpora lutea in the cyclic rat: possible involvement of luteal endothelial cell progesterone receptors. J. Endocrinol. 165:2000;715-724.
13. Gerdes D., Christ M., Haseroth K., Notzon A., Falkenstein E., Wehling M. Nongenomic actions of steroids - from the laboratory to clinical implications. J. Pediatr. Endocrinol. Metab. 13:2000;853-878.
14. Hazzard T.M., Molskness T.A., Chaffin C.L., Stouffer R.L. Vascular endothelial growth factor and angiopoietin regulation by gonadotropin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol. Hum. Reprod. 5:1999;1115-1121.
15. Hild-Petito S., Stouffer R.L., Brenner R.M. Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology. 123:1988;2896-2905.
16. Kawano T., Okamura H., Tajima C., Fukuma K., Katabuchi H. Effect of RU486 on luteal function in the early pregnant rat. J. Reprod. Fertil. 83:1988;279-285.
17. Kobayashi H., Okada Y., Asahina T., Gotoh J., Terao T. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome. J. Mol. Endocrinol. 20:1998;363-374.
18. Krasnow J.S., Berga S.L., Guzick D.S., Zeleznik A.J., Yeo K.T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril. 65:1996;552-555.
19. Lee A., Burry K.A., Christenson L.K., Patton P.E., Stouffer R.L. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil. Steril. 68:1997;305-311.
20. Lei Z.M., Chengini N., Rao C.V. Quantitative cells composition of human and bovine corpora lutea from various reproductive states. Biol. Reprod. 44:1991;1148-1156.
21. Leung D.W., Cachianes G., Kuang W.-J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
22. Levin E.R., Rosen G.F., Cassidenti D.L., Yee B., Meldrum D., Wisot A., et al. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J. Clin. Invest. 102:1998;1978-1985.
23. Ludwig M., Bauer O., Lopens A., Jelkmann W., Diedrich K. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum. Reprod. 13:1998;30-32.
24. Ludwig M., Jelkmann W., Bauer O., Diedrich K. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotropin administration. Hum. Reprod. 14:1999;2437-2441.
25. Monacci W., Merrill M., Oldfield E. Expression of vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 264:1993;C995-C1002.
26. Schenker J.G., Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril. 30:1978;255-268.
27. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
28. Simon A., Revel A., Hurwitz A., Laufer N. The pathogenesis of ovarian hyperstimulation syndrome: a continuing enigma. J. Assist. Reprod. Genet. 15:1998;202-209.
29. Tanaka N., Iwamasa J., Matsuura K., Okamura H. Effects of progesterone and anti-progesterone RU486 on ovarian 3β-hydroxysteroid dehydrogenase activity during ovulation in the gonadotropin-primed immature rat. J. Reprod. Fertil. 97:1993;167-172.
30. Telleria C.M., Stocco C.O., Stati A.O., Deis R.P. Progesterone receptor is not required for progesterone action in the rat corpus luteum of pregnancy. Steroids. 64:1999;760-766.
31. Ujioka T., Matsuura K., Kawano T., Okamura H. Role of progesterone in capillary permeability in hyperstimulated rats. Hum. Reprod. 12:1997;1629-1634.
32. Ujioka T., Matsuura K., Tanaka N., Okamura H. Involvement of ovarian kinin-kallikrein system in the pathophysiology of ovarian hyperstimulation syndrome: studies in a rat model. Hum. Reprod. 13:1998;3009-3015.